ArticleBMC cancer2022

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer.

Jun Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.